<DOC>
	<DOCNO>NCT01038869</DOCNO>
	<brief_summary>Residual post-inflammatory hyperpigmentation ( PIH ) acne disturb individual skin color . Finacea anecdotally know beneficial resolve PIH related acne vulgaris . However , clinically test purpose . The current study investigate efficacy safety Finacea treatment acne vulgaris PIH .</brief_summary>
	<brief_title>Efficacy Safety Study Finacea Treat Acne Vulgaris Post-Inflammatory Hyperpigmentation ( PIH )</brief_title>
	<detailed_description />
	<mesh_term>Acne Vulgaris</mesh_term>
	<mesh_term>Hyperpigmentation</mesh_term>
	<mesh_term>Azelaic acid</mesh_term>
	<criteria>Male female , least 12 year age Female subject childbearing potential must negative urine pregnancy test Baseline Fitzpatrick skin type IV VI Acne IGA ( Investigator Global Assessment ) score 2 3 Inflammatory lesion 1560 ( 2 nodule ) Noninflammatory lesion 20100 Post Inflammatory Hyperpigmentation Investigator Global Assessment ( PIH IGA ) score 3,4 5 Able understand requirement study sign Informed Consent/HIPAA form . Subjects legal age consent must write informed consent parent legal guardian Female subject pregnant , breastfeed childbearing potential practicing reliable method birth control Allergy sensitivity component test medication Subjects comply wash period prohibit medication Medical condition contraindicates participation Skin disease/disorder might interfere diagnosis acne vulgaris PIH Evidence recent alcohol drug abuse History poor cooperation , noncompliance unreliability Exposure investigational drug study within 30 day Baseline visit</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2012</verification_date>
</DOC>